Facebook Pixel Ayurveda market booms in India even as US tariffs deliver a blow | Chronicle Pharmabiz - health - Bu hikayeyi Magzter.com'da okuyun
Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Ayurveda market booms in India even as US tariffs deliver a blow

Chronicle Pharmabiz

|

December 11, 2025

INDIA'S Ayurveda sector is experiencing strong domestic momentum, driven by rising consumer preference for natural wellness products, expanded retail presence, and greater government support for Ayush initiatives.

- Nandita Vijayasimha, Bengaluru

However, this growth surge contrasts sharply with challenges emerging in international trade, as the newly imposed US customs tariffs have increased costs for key herbal ingredients and extracts sourced from India. The duties are straining exporters, reducing competitiveness in one of their largest markets, and creating uncertainty for companies that rely heavily on US demand, even as the industry thrives at home.

Chronicle Pharmabiz'den DAHA FAZLA HİKAYE

Chronicle Pharmabiz

Devices sector raises concern over notification proposing fee for tests

THE medical devices industry has raised concern over the Department of Health and Family Welfares' draft notification introducing fee for test or evaluation of medical devices and mandating inclusion of licence number of sub contractor on the product labels. The Department published the draft notification on April 10, proposing various amendments to the Medical Devices Rules (MDR), 2017 including introduction of fee for test or evaluation of 11 types of tests or evaluation.

time to read

2 mins

April 30, 2026

Chronicle Pharmabiz

Panel asks DoP to take efforts to decrease imported content in medical devices

OBSERVING that a majority of the medical devices market is addressed by imports, the Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DOP) to take measures including promotion of stronger collaboration among the industry, academic institutions and research organisations to accelerate indigenous development of advanced medical devices.

time to read

1 mins

April 30, 2026

Chronicle Pharmabiz

AI in endoscopy will improve detecting early-stage cancer markers

INDIA has been moving steadily towards better cancer care. However, many cancers in India are still detected late, especially those in the digestive system.

time to read

2 mins

April 30, 2026

Chronicle Pharmabiz

Telangana appoints DG of DCA as compounding authority

IN a significant move to streamline regulatory compliance under the newly enacted Jan Vishwas provisions, the Government of Telangana has officially designated the Director General (DG) of the state’s Drugs Control Administration (DCA), Shahnawas Quasim, as the 'Compounding Authority'.

time to read

2 mins

April 30, 2026

Chronicle Pharmabiz

AIOCD seeks PM's intervention against e-pharmacies

THE All India Organisation of Chemists & Druggists (AIOCD), representing over 12.40 lakh pharmacists and distributors, has formally petitioned Prime Minister Narendra Modi to intervene against the unregulated growth of e-pharmacies and predatory pricing by large corporate entities.

time to read

1 mins

April 30, 2026

Chronicle Pharmabiz

Shed The Cavalier Attitude

A Parliamentary Panel has recently asked the Department of Pharmaceuticals (DoP) to take corrective steps to remove any administrative and procedural delays related to the Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.

time to read

2 mins

April 30, 2026

Chronicle Pharmabiz

DCOIWA slams new DCGI recruitment rules, cites dilution of tech standards

THE Drugs Control Officers (I) Welfare Association (DCOIWA), the national body of drug regulatory officers in the country, has criticised the Union Heath Ministry's newly notified recruitment rules for the post of DCGI, labelling them as a serious policy lapse.

time to read

1 mins

April 30, 2026

Chronicle Pharmabiz

Experts highlight the need for data exclusivity to protect MSMES

EXPERTS have highlighted the need for clinical data exclusivity in order to protect MSME drug innovators in India.

time to read

2 mins

April 30, 2026

Chronicle Pharmabiz

Mid-sized hospitals in Tier-2 cities stranded in a financial vacuum: Expert

MID-sized hospitals in Tier-2 cities are currently trapped in a financial vacuum. This is because funding usually arrives either too early as venture capital or too late as a financial buyout, said Rakshith Rangarajan, equity fund manager, Inviga Investment Advisors.

time to read

2 mins

April 30, 2026

Chronicle Pharmabiz

Indian healthcare sector faces escalating cyber risks

INDIAN healthcare sector is confronting a surge in cyber threats as increasingly complex hospital IT ecosystems create multiple vulnerabilities for potential breaches.

time to read

2 mins

April 30, 2026

Listen

Translate

Share

-
+

Change font size